PARP Inhibitor Protects Against Chronic Hypoxia/Reoxygenation-Induced Retinal Injury by Regulation of MAPKs, HIF1α, Nrf2, and NFκBKrisztina Kovács(University of Pecs), Balázs Sümegi(University of Pecs)Investigative Ophthalmology & Visual ScienceApril 11, 201910.1167/iovs.18-25936Cited by 39SaveCiteExport RISWatch citationsRelated PapersActivation of mitochondrial fusion provides a new treatment for mitochondria-related diseases|Biochemical Pharmacology|2018|97PARP Inhibition Attenuates Acute Kidney Allograft Rejection by Suppressing Cell Death Pathways and Activating PI-3K-Akt Cascade|PLoS ONE|2013|17